Public-record analysis · Sources reviewed October 28, 2026.

Food packaging is a powerful subject for a headline, but regulatory scope matters. FDA’s statements about fluorinated polyethylene should be read with their qualifications intact. The documents raise questions about process conditions and potential migration; they do not justify claiming that every food product associated with Inhance Technologies has been shown to be contaminated.

The 2021 letter and its qualification

FDA’s August 5, 2021 update reminded manufacturers and distributors that only certain fluorinated polyethylene containers are authorized for food-contact use. It explained that EPA’s referenced testing involved containers for a mosquito-control pesticide, a context outside the food-contact applications being discussed. [1]

The update also said FDA had no evidence that the alternative fluorination processes it discussed were being used to manufacture food containers. That qualification is essential. A report that omits it can turn a warning about manufacturing conditions into an unsupported claim about the entire food supply.

Why the manufacturing process belongs in the assessment

The regulatory question is not answered by the word plastic alone. The type of article, treatment conditions and intended use all matter. A supplier’s statement about one application should not automatically be extended to another. A food-contact claim needs to identify the process and requirements it concerns.

Likewise, a pesticide-container experiment is not a substitute for testing a particular food-contact article under relevant conditions. The experiment may motivate further inquiry, but the comparison must be made explicitly. Readers should be able to see whether a conclusion is based on direct testing, a model or an analogy.

What the dated 2026 review table adds

FDA’s table dated May 12, 2026 lists fluorinated HDPE under review of information and refers to data and comments from the earlier request for information. That entry describes review activity. It is not a product-specific clearance for Inhance and not a finding that every item in the category is unsafe. [2]

A dated status entry should be reported as such. It can change, and a responsible update would identify a later operative action separately rather than rewriting a historical notice into a present-tense blanket claim. This article describes the cited documents, not a complete determination of every food-contact requirement.

The questions a useful investigation would answer

For a particular package, a source file should identify the manufacturer or treatment provider, material, intended contents, treatment period and available compliance and migration evidence. The relevant laboratory report should explain its sample, method and limits. A brand name alone does not provide those details.

The public-interest task is to connect the regulatory question with a real article and use. That can support careful scrutiny of Inhance Technologies and its customers’ packaging choices without pretending that the reviewed FDA documents prove a universal poisoning claim. No new food testing was commissioned for this article.

Sources and further reading

  1. FDA, fluorinated polyethylene food-contact container letter, August 5, 2021
  2. FDA, selected chemicals in the food supply under review, table dated May 12, 2026
  3. EPA, PFAS in pesticide and other packaging

This article distinguishes agency findings, company positions, pleadings and court holdings. It reports no newly verified individual disease case attributable to Inhance Technologies or Prakash Iyer. No direct interview, medical testing or independent reproduction of laboratory data was conducted for this edition.